Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 1,160 | 585 | -172 | 414 | 1,248 |
| Operating Income | -1,160 | -585 | 172 | -414 | -1,248 |
| Other Income | 1,196 | 20 | -4 | -12 | 11 |
| Pre-tax Income | 35 | -565 | 168 | -426 | -1,237 |
| Net Income Continuous | 35 | -565 | 168 | -426 | -1,237 |
| Net Income | $35 | $-565 | $168 | $-426 | $-1,237 |
| EPS Basic Total Ops | 0.01 | -0.09 | 0.04 | -0.10 | -0.32 |
| EPS Basic Continuous Ops | 0.01 | -0.10 | 0.04 | -0.10 | -0.32 |
| EPS Diluted Total Ops | 0.01 | -0.09 | 0.04 | -0.10 | -0.32 |
| EPS Diluted Continuous Ops | 0.01 | -0.10 | 0.04 | -0.10 | -0.32 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.12 | 0.04 | N/A | N/A |
| EBITDA(a) | $-1,145 | $-570 | $184 | $-400 | $-1,234 |